In view of the current widespread of COVID-19 and to reduce social contact, consumers are advised to call our hotline at 2929 2222 or make use of our web forms via the following links:
Consumers may also call our hotline at 2929 2222 for gift redemption and enquiry services at our Consumer Advice Centres by appointment if needed.
Recall of two pharmaceutical products (with photos)
The Department of Health (DH) today (September 14) endorsed a licensed drug wholesaler, Suntol Medical Ltd (Suntol), to recall Royalsense Acne Gel 1% (Hong Kong Registration Number: HK-48233) and Lysozyme Tablets 90mg (Sinphar) (Hong Kong Registration Number: HK-48153), from the market as a precautionary measure due to a stability issue.
The DH received notification from Suntol that Royalsense Acne Gel 1% and Lysozyme Tablets 90mg (Sinphar) are being recalled in Taiwan, as the content of active ingredients in the products failed to meet the product specifications during a long-term stability study. Though the products would not cause a health harm to users, the issue might affect the efficacy of the products. As a precautionary measure, Suntol is recalling the products in Hong Kong.
Royalsense Acne Gel 1%, containing clindamycin, is a prescription medicine used for the topical treatment of acne. Lysozyme Tablets 90mg (Sinphar), containing lysozyme, is an over-the-counter medicine used as adjunctive treatment for certain inflammatory conditions. According to Suntol, the products have been supplied to local private doctors and pharmacies.
Suntol has set up a hotline (2546 5699) to answer related enquiries.
"So far, the DH has not received any adverse reaction reports in connection with the products. The DH will closely monitor the recall," a spokesman for the DH said.
"Patients who are using the above products should seek advice from their healthcare professionals for appropriate arrangements," the spokesman added.
Reposted from HKSAR Government webpage: